Nuwellis (NUWE) EBT Margin Growth (5y) (2018 - 2026)
Nuwellis (NUWE) EBT Margin Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn |
| 10 | Nuwellis | 208,900.69 | -3.71 Mn | 1.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5,668.00 |
| Mar 31, 2026 | 8,313.00 |
| Dec 31, 2025 | 5,282.00 |
| Sep 30, 2025 | 24,469.00 |
| Jun 30, 2025 | -51,706.00 |
| Mar 31, 2025 | 12,188.00 |
| Dec 31, 2024 | 26,257.00 |
| Sep 30, 2024 | 45,968.00 |
| Jun 30, 2024 | -8,796.00 |
| Mar 31, 2024 | 15,582.00 |
| Dec 31, 2023 | 6,659.00 |
| Sep 30, 2023 | 17,144.00 |
| Jun 30, 2023 | 14,686.00 |
| Mar 31, 2023 | 6,483.00 |
| Dec 31, 2022 | 77,642.00 |
| Sep 30, 2022 | 10,966.00 |
| Jun 30, 2022 | 9,079.00 |
| Mar 31, 2022 | -12,781.00 |
| Dec 31, 2021 | 131,652.00 |
| Sep 30, 2021 | 44,893.00 |